Catalyst Event

Livzon Pharmaceutical Group Inc (1513) · Other

From Akros SCHK HK-Global Genomics Index (ASHGGENM)

4/29/2026, 12:00:00 AM

OtherSentiment: Positive

The company announced its subsidiary completed a public tender offer on 2026-04-29, acquiring a 67.87% controlling stake in Vietnam-listed Imexpharm Corporation for approximately RMB 1.562 billion, deepening its presence in the Vietnam pharmaceutical market.

Korean Translation

자회사가 공개매수를 완료하여 2026-04-29 베트남 상장사인 이멕스팜(Imexpharm Corporation)의 지배지분 67.87%를 약 15억 6,200만 위안에 인수하여 베트남 제약 시장에 대한 입지를 강화했다고 발표함.

Related Recent Events

View Full Timeline